Biomimiq is operated by a team of experienced scientists and business professionals. Get to know your partners in healthy and diseased in vitro human skin testing.
Abdoel was trained as a molecular cell biologist at the Université Pierre et Marie Curie (Paris VI) in France. He has worked on the development and optimization of human skin equivalents (HSEs) since 1998 at the tissue engineering company IsoTis. In 2004, Abdoel obtained his PhD on research conducted at the Department of Dermatology at the Leiden University Medical Center (LUMC) in Leiden, The Netherlands, where he optimized the HSEs and extensively investigated the use of HSEs for research, diagnostic and clinical purposes. Currently, he holds a position as assistant professor in the Department of Dermatology of the LUMC and is leading the academic research group on diseased skin models, including in vitro models of skin cancer, eczema, skin aging, wound healing and skin infection. In 2008, Abdoel won the public ‘Alternatives to Animal Use’ Award for in vitro skin models.
Liesbeth Hameetman, PhD
Liesbeth was trained as a biopharmaceutical scientist at the Leiden University. In 2007, she obtained her PhD on research conducted at the department of Pathology at the Leiden University Medical Center (LUMC) in Leiden, the Netherlands, where she investigated the role of EXT genes and growth signaling pathways in cartilaginous tumors. Liesbeth’s first post-doc project was a collaboration between the departments of Toxicogenetics (now Human Genetics) and Dermatology at the LUMC and focused on the molecular profiling of non-melanoma skin cancers. During this project she also collaborated with Abdoel and colleagues at the LUMC to optimize skin cancer HSEs. A second post-doc project at the Dermatology department focused on the validation of new small molecules to inhibit the EPHA4 kinase in skin lymphomas. After almost three years as account manager for Bio-connect, Liesbeth decided to combine her scientific background with her sales experience and made the switch to Biomimiq as project manager.
Marjolein was trained as a research technician at the University of Applied Sciences Leiden, the Netherlands, within the programme of Biology and Medical Laboratory Research, followed by a Master's Programme in Oncology at the VU University Medical Center in Amsterdam, the Netherlands. Her final research project focused on the effects of hypoxia on in vitro human skin cancer models. Marjolein's experience with three-dimensional human skin cultures now serves Biomimiq's customers.
Marieke was trained as a life science engineer at Leiden University and Delft University of Technology in the Netherlands. Her research internship focused on the use of human skin equivalents (HSEs) in squamous cell carcinoma research. Thereafter, she performed a business internship at Aeon Astron Europe B.V. focusing on HSE market development. After her graduation, Marieke started working as research technician for Biomimiq’s service activities.
Ana was trained as a biomedical engineer at the University of Minho, Braga in Portugal. Her master thesis focused on the use of starch-based scaffolds to induce osteogenic differentiation on human adipose stem cells. Thereafter, she focused her research on the influence of inorganic ions on human mesenchymal stem cells towards the osteogenic lineage at 3Bs Research Group in Portugal as well as at Tissue Regeneration Group, University of Twente, the Netherlands. In January 2016, Ana started working as research technician for Biomimiq’s service activities.
Kenn Curt Daniël (Chief Operating Officer)
Michael Lai (Chief Executive Officer)